T-588 inhibits astrocyte apoptosis via mitogen-activated protein kinase signal pathway

Citation
K. Takuma et al., T-588 inhibits astrocyte apoptosis via mitogen-activated protein kinase signal pathway, EUR J PHARM, 399(1), 2000, pp. 1-8
Citations number
42
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
399
Issue
1
Year of publication
2000
Pages
1 - 8
Database
ISI
SICI code
0014-2999(20000630)399:1<1:TIAAVM>2.0.ZU;2-9
Abstract
The effect of (1R)-1-benzo[b]thiophen-5-yl-2-[2-(diethylamino)ethoxy]ethan- 1-ol hydrochloride (T-588), a cognition enhancer, on reperfusion injury was studied in cultured rat astrocytes. T-588 at 1-10 mu M partially protected astrocytes against reperfusion injury after exposure to Ca2+-free medium o r hydrogen peroxide, Nerve growth factor (NGF) had a similar protective eff ect. Addition of both T-588 and NGF resulted in complete protection against Ca2+ reperfusion injury. T-588 did not stimulate NGF production in astrocy tes. The effect of T-588 on Ca2+ reperfusion injury including apoptosis was inhibited by the mitogen-activated protein (MAP)/extracellular signal-regu lated kinase (ERK) kinase inhibitor 2'-amino-3'-methoxyflavone (PD98059), b ut not by the phosphoinositide S-kinase inhibitor wortmannin. The effect of NGF was inhibited by PD98059 and wortmannin. T-588 stimulated rapidly the phosphorylation of ERK, but did not affect that of Akt in astrocytes, These findings suggest that the ERK MAP kinase pathway has a role in the protect ive effects of T-588 and NGF. (C) 2000 Elsevier Science B.V. All rights res erved.